SCHEMBL2529031

SCHEMBL2529031

CCCCC[SiH](O[SiH](CCCCC)N(C)C)N(C)C

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.35
TSHR P16473 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3632115 0.98 DNM1 (0.39) DNM1TSHRTHRB
SCHEMBL3629406 0.92 DNM1 (0.31) DNM1TSHR
SCHEMBL3630886 0.81
SCHEMBL28922190 0.69 TSHR (0.44) DNM1TSHRTHRB
SCHEMBL671910 0.67 TSHR (0.41) DNM1TSHRTHRB
SCHEMBL28204325 0.67 DNM1 (0.36) DNM1TSHRTHRB
SCHEMBL16281515 0.65 TSHR (0.39) DNM1TSHRTHRB
Hexane SCHEMBL1972103 0.64 TSHR (0.64) DNM1TSHRTHRB
Hexane SCHEMBL5792569 0.64 TSHR (0.64) DNM1TSHRTHRB
SCHEMBL9277808 0.63 TSHR (0.37) TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2389157-A1 DRUG DELIVERY SYSTEM FOR USE IN THE TREATMENT OF VASCULAR AND VESSEL-RELATED PATHOLOGIES Academisch Medisch Centrum (NL) 2011-11-30 EP disclosed
US-8038960-B2 Improves thermal efficiency by heating both inner and outer side surfaces of double cylindrical reforming chamber by combustion gas produced when burner is turned on, and in the reforming chamber, providing \"return pipes\" through which a produced reformed gas flows IDEMITSU KOSAN CO., LTD. (JP) 2011-10-18 US disclosed
WO-2010084199-A1 DRUG DELIVERY SYSTEM FOR USE IN THE TREATMENT OF VASCULAR AND VESSEL-RELATED PATHOLOGIES ACADEMISCH MEDISCH CENTRUM (NL) 2010-07-29 WO disclosed
EP-2210590-A1 Drug delivery system for use in the treatment of vascular and vessel-related pathologies Academisch Medisch Centrum (NL) 2010-07-28 EP disclosed